# FDA Inspection 1206196 - Seven Star Pharmaceutical Co., Ltd. - April 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/seven-star-pharmaceutical-co-ltd/3d1e2eb0-e7c4-413c-a291-486e04fa1cc4
Source feed: FDA_Inspections

> FDA Inspection 1206196 for Seven Star Pharmaceutical Co., Ltd. on April 21, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1206196
- Company Name: Seven Star Pharmaceutical Co., Ltd.
- Inspection Date: 2023-04-21
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1062088 - 2018-07-06](https://www.keypedia.com/records/fda_inspections/seven-star-pharmaceutical-co-ltd/7fdf62aa-2d74-4021-91aa-aa8ae6efe40b)
- [FDA Inspection 970157 - 2016-04-29](https://www.keypedia.com/records/fda_inspections/seven-star-pharmaceutical-co-ltd/de4281dc-de3b-4c3d-aed5-7c7b5931b973)
- [FDA Inspection 816467 - 2013-01-11](https://www.keypedia.com/records/fda_inspections/seven-star-pharmaceutical-co-ltd/7d174407-296f-451f-8561-63bccd0fe1a5)

Company: https://www.keypedia.com/companies/seven-star-pharmaceutical-co-ltd/216769b2-09e4-44d7-af06-0cc8ed738543

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c